3/A

FORM 3/A SUBMISSION

Company: Stoke Therapeutics, Inc.
Filed: April 15, 2020
Period of Report: June 18, 2019
Accession Number: 0001209191-20-024540

View Document ↗ View on SEC.gov ↗